A new treatment for advanced prostate cancer has been shown to extend the lifespans of the affected men by as much as one year, researchers said Sunday. The study involved 790 men who were diagnosed with metastatic prostate cancer, meaning the disease had spread beyond the prostate. By adding the chemotherapy drug docetaxel to standard hormone therapy, known as androgen deprivation therapy (ADT), fewer patients died and many lived longer. After ...
via Medindia Health News More READ
No comments:
Post a Comment